Abstract:Coronary microvascular disease (CMD) and its progression towards major adverse coronary events pose a significant health challenge. Accurate in vitro investigation of CMD requires a robust cell model that faithfully represents the cells within the cardiac microvasculature. Human pluripotent stem cell-derived endothelial cells (hPSC-ECs) offer great potential; however, they are traditionally derived via differentiation protocols that are not readily scalable and are not specified towards the microvasculature. Here, we report the development and comprehensive characterisation of a scalable 3D protocol enabling the generation of phenotypically stable cardiac hPSC-microvascular-like ECs (hPSC-CMVECs) and cardiac pericyte-like cells. These were derived by growing vascular organoids within 3D stirred tank bioreactors and subjecting the emerging 3D hPSC-ECs to high-concentration VEGF-A treatment (3DV). Not only did this promote phenotypic stability of the 3DV hPSC-ECs; single cell-RNA sequencing (scRNA-seq) revealed the pronounced expression of cardiac endothelial- and microvascular-associated genes. Further, the generated mural cells attained from the vascular organoid exhibited markers characteristic of cardiac pericytes. Thus, we present a suitable cell model for investigating the cardiac microvasculature as well as the endothelial-dependent and -independent mechanisms of CMD. Moreover, owing to their phenotypic stability, cardiac specificity, and high angiogenic potential, the cells described within would also be well suited for cardiac tissue engineering applications.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to develop a robust and scalable in - vitro cell model to accurately simulate human pluripotent stem cell - derived cardiac microvascular endothelial cells (hPSC - CMVECs) and cardiac pericyte - like cells for the study of coronary microvascular disease (CMD). Specifically, the research aims to: 1. **Overcome the limitations of existing models**: Traditional cardiac microvascular endothelial cell models have problems of heterogeneity and instability. In particular, endothelial - mesenchymal transition (EndMT) is likely to occur during long - term culture, causing cells to lose their endothelial characteristics. In addition, traditional two - dimensional (2D) culture methods cannot fully simulate the complex three - dimensional (3D) microenvironment in vivo. 2. **Generate stable and cardiac - specific endothelial cells**: By optimizing the differentiation protocol and using high - concentration vascular endothelial growth factor A (VEGF - A) treatment, researchers hope to generate endothelial cells that are more stable in both morphology and function and can express genes related to cardiac microvessels. 3. **Provide a cell model suitable for disease modeling and tissue engineering applications**: The generated cells can be used not only to study CMD and its related mechanisms but also for cardiac tissue engineering, providing a basis for the development of new treatment methods. ### Research background The cardiac microvessels have been long - neglected, and their role in cardiovascular diseases has not been fully emphasized. With the development of advanced non - invasive imaging techniques, people have gradually recognized the importance of the microvascular network and how it is affected by cardiovascular risk factors. These factors can trigger endothelial - dependent and non - endothelial - dependent mechanisms, disrupting blood flow in the microvessels, thereby affecting the oxygen supply to the myocardium. This microvascular dysfunction is called coronary microvascular disease (CMD), which may lead to microvascular angina and even develop into major adverse cardiovascular events (MACE). ### Main research content 1. **Limitations of 2D culture**: Research shows that human pluripotent stem cell - derived endothelial cells (hPSC - ECs) obtained through 2D culture are likely to lose their endothelial characteristics during long - term culture and exhibit mesenchymal features. This indicates that the 2D culture method is not suitable for generating a stable endothelial cell model. 2. **Advantages of 3D culture**: Researchers have developed a protocol based on 3D suspension culture to generate vascular organoids in a Matrigel - free environment. By separating CD31 - positive cells through fluorescence - activated cell sorting (FACS) for analysis, it was found that these cells showed better homogeneity and a higher proportion of CD31 - positive cells in the 3D environment. 3. **The role of high - concentration VEGF - A**: Further research shows that high - concentration VEGF - A treatment can significantly improve the long - term culture stability of 3D hPSC - ECs, enhance their endothelial characteristics, and inhibit the occurrence of EndMT. These cells also exhibit a gene expression profile similar to that of cardiac microvascular endothelial cells. 4. **Single - cell RNA sequencing (scRNA - seq) analysis**: By performing scRNA - seq analysis on endothelial cells from different sources, researchers found that 3D VEGF - A - treated hPSC - ECs (3DV hPSC - ECs) formed independent clusters and expressed markers related to cardiac microvascular endothelial cells, while other cell types showed different characteristics. ### Conclusion Through the above research, the authors have successfully developed a robust and scalable 3D culture protocol that can generate stable cardiac microvascular endothelial cells and pericyte - like cells in vitro. These cells are not only closer to natural cardiac microvascular endothelial cells in terms of morphology and function but also show a high degree of cardiac specificity at the gene expression level. This achievement provides a powerful tool for studying CMD and its related mechanisms and lays a foundation for cardiac tissue engineering and new drug development.

Generation and characterisation of scalable and stable human pluripotent stem cell-derived microvascular-like endothelial cells for cardiac applications

Human Induced Pluripotent Stem Cell for Modeling Cardiovascular Diseases.

Generation and maturation of human iPSC-derived 3D organotypic cardiac microtissues in long-term culture

Scalable Cardiac Differentiation of Pluripotent Stem Cells Using Specific Growth Factors and Small Molecules

Synergistic generation of cardiac resident-like macrophages and cardiomyocyte maturation in tissue engineered platforms

Co‐Differentiation of Human Pluripotent Stem Cells‐Derived Cardiomyocytes and Endothelial Cells from Cardiac Mesoderm Provides a Three‐Dimensional Model of Cardiac Microtissue

Generation and Characterization of hiPSC-Derived Vascularized-, Perfusable Cardiac Microtissues-on-Chip

New Modalities of 3D Pluripotent Stem Cell-Based Assays in Cardiovascular Toxicity

Generation and characterization of cardiac valve endothelial-like cells from human pluripotent stem cells

Micro‐Engineered Heart Tissues on‐Chip with Heterotypic Cell Composition Display Self‐Organization and Improved Cardiac Function

hESCs‐Derived Early Vascular Cell Spheroids for Cardiac Tissue Vascular Engineering and Myocardial Infarction Treatment

Generation, Expansion and Functional Analysis of Endothelial Cells and Pericytes Derived from Human Pluripotent Stem Cells

Endothelial extracellular vesicles enhance vascular self-assembly in engineered human cardiac tissues

Generation of a human iPSC-derived cardiomyocyte/fibroblast engineered heart tissue model

Single-cell RNA sequencing reveals maturation trajectory in human pluripotent stem cell-derived cardiomyocytes in engineered tissues

Integrated multi-omics analysis identifies features that predict human pluripotent stem cell-derived progenitor differentiation to cardiomyocytes

Advancing Cardiovascular Drug Screening Using Human Pluripotent Stem Cell-Derived Cardiomyocytes

Functionality of Endothelial Cells and Pericytes from Human Pluripotent Stem Cells Demonstrated in Cultured Vascular Plexus and Zebrafish Xenografts.

Human Pluripotent Stem Cell-Derived Cardiac Cells: Application in Disease Modeling, Cell Therapy, and Drug Discovery

Engineered Cardiac Microtissue Biomanufacturing Using Human Induced Pluripotent Stem Cell-Derived Epicardial Cells

Optimizing mesoderm progenitor selection and three-dimensional microniche culture allows highly efficient endothelial differentiation and ischemic tissue repair from human pluripotent stem cells